We have enjoyed years of collaboration with Insight who consistently provides creativity and innovation in ways that are aligned with our design control system and quality processes. Creating game changing delivery solutions while adhering to Quality System Requirements are what our customers expect of us.”
Pharma Delivery Devices and Systems
Mitigate risk, encourage adherence and foster brand loyalty
Trends in the pharmaceutical industry are pushing companies to innovate beyond molecules and their delivery. Increasingly, the market demands solutions that exceed what low-cost and stock delivery devices offer. Competitive pressures and technology convergence are redefining opportunity in the industry; now, delivery devices also need to manage information, provide support to users, and connect with consumers at an emotional level.
Insight’s approach to development, based on understanding users and their environments, and coupled with our focus on mitigating risk, gives us the experience needed to help you develop a successful combination product or other delivery device.
Beyond the Basics
More about risk, adherence and loyalty
Consolidation in the industry and commoditization of therapies has placed a premium on building the value of drug franchises through improved delivery systems. Insight’s extensive device experience has given us a complete understanding of how to achieve meaningful differentiation by accounting for the following:
Mitigating project and product risk
Insight’s formal QMS system and human factors expertise are designed to mitigate project and regulatory risks. We understand the differences between systems administered by the patient and unskilled caregivers from those used by trained clinicians. Our research process ensures that the product is a success in terms of safety and adherence.
Encouraging patient adherence
We understand the use patterns and environment aspects of home healthcare and employ methods that reveal the emotional side of self-administering. This ensures that a delivery device is designed to support the patient physically, cognitively and emotionally to give the best chance at enabling adherence.
Fostering brand loyalty
As direct-to-consumer marketing matures, drug therapy solutions grow increasingly inseparable from their delivery devices. Patients, caregivers and clinicians now have more choices than ever when selecting among drug options. Creating the best user experience by supporting the emotional side of care creates strong connections between users and your brand that can make your offering the preferred option.
The complexities of the patient
Understanding users and their environments in discretely different ways is critical to the development of an optimal delivery solution.
 |
The Patient’s Mind, which let’s us know their attitudes and emotions about their health and their disease state. This tells us how invested they are in managing their care and lets us know how much they are WILLING to do to that end. This allows us to design solutions that can make positive emotional connections with users and better support patient compliance and brand loyalty. |
 |
The Patient’s Body, which lets us know what they are capable of physically and cognitively. This enables us to design solutions that are easy to understand and use, that are safe to use, and that perform in a reliable manner not prone to failure due to user error. |
 |
The Patient’s Environment, which helps us understand the circumstances and conditions that patients are in as they manage their care and the kind of support they receive from those around them. This helps us understand how to develop solutions that provide value across many environmental variables and identifies opportunities for how solutions can better integrate with user lifestyles. |
 |
The Patient’s Clinical Connection, and the new roles that clinicians need to adopt beyond administering therapies in order to provide the best possible care to their patients. This means understanding the clinician as educator, trainer, troubleshooter, distributor, and unofficial advocate for drug delivery devices and systems. |
A systemic approach to therapy
Trends in the pharmaceutical industry and shifts in patient attitudes toward health management are introducing new complexities that need to be addressed by delivery devices. Drug delivery solutions need to adopt a more systemic approach that considers the molecule and delivery device in tandem with peripheral products and support services and provides more robust experiences to customers.
Delivery systems which are increasingly more complex such as electro-mechanical patient mounted delivery systems, patch pumps, and metered dose inhalers
Peripheral products that can both complement the delivery experience for patients and collect useful information for caregivers
Support services such as web experiences, mobile device applications, and online peer to peer communities that empower and support patients utilizing technologies that complement their lifestyles
Our experiences
Insight has helped our clients develop a wide variety of combination products and other delivery systems. This work, driven by user research, has ranged from solutions for trained clinicians operating in clinical environments to those for unskilled patients and caregivers to use at home. Our experience includes:
- Auto-injectors
- Extended delivery patch pumps
- Safety syringes
- Metered dry powdered inhalers
- Diabetes care products
- Biologics delivery systems
We partner with our clients in a variety of ways, whether engaged over an extended period of time to deliver turn-key solutions or tactical engagements that range from mechanical innovation activities to development and execution of a human factors plan and research to define delivery systems workflows.
Whether we are involved in a turnkey program or a task specific project, we can provide:
- In-context user research and workflow mapping
- Development and execution of the human factors plan
- Design to apply HF and visual brand principles
- Mechanism design, breadboarding and testing
- Project, product, process and user based risk management
Emerging market opportunities
With the growth of the global pharmaceutical industry expected to rise in the next 3 years to just under a trillion dollars annually, and emerging markets accounting for 30% of the global market, opportunities for growth can be found all over the world. The growth rate of the top eight industrialized countries ranges between 1% and 8% while the top seven emerging markets (Brazil, Russia, India, China, Mexico, Turkey and South Korea) are averaging between 8% and 21%.
Insight has performed research in six of the seven fastest growing emerging markets. We understand how to interpret the user variances between cultures and we know how to overcome logistical challenges in performing the actual research itself.
We can help you understand:
- Payer systems in emerging markets
- The inter-relationship of traditional and modern medicine
- Shifting roles in who provides care for patients and where it happens
- Social stigmas around treatment and how it varies across different cultures
- How economics impact the way in which low income families manage treatment
Related Topics:
Relevant Case Studies:
